Relmada Therapeutics Inc
RLMD·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$3.80
Today
+0.5%
YTD
-21.8%
About
Relmada Therapeutics, Inc. is a late-stage biotechnology company with a focus on the treatment of central nervous system diseases. Based in New York City, the company was founded in 2004 and is listed on the NASDAQ GS with the ticker RLMD. Diversify your portfolio on eToro by buying RLMD stock today.
Price chart
Closing price history for RLMD (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-5.76
P/S (TTM)0.00
P/B (TTM)3.07
Market cap$672.34M
Cap tierSmall-cap
Industry avg P/E-43.35
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-48.83%
ROA-44.77%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$1.11
Free cash flow$-42.79M
Total debt$0.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.53
Employees17
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.